Technical Analysis for IMVIQ - Imv Inc

Grade Last Price % Change Price Change
D 0.0800 0.00% 0.0000
IMVIQ closed unchanged on Friday, June 2, 2023, on 25 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Down

Date Alert Name Type % Chg
Gapped Up Strength 0.00%
Doji - Bullish? Reversal 0.00%
Gapped Up Strength 0.00%
Doji - Bullish? Reversal 14.29%
Gapped Down Weakness 14.29%
Hot IPO Pullback Bullish Swing Setup -20.00%
Gapped Down Weakness -20.00%
Gapped Up Strength 0.00%
Shooting Star Candlestick Bearish -20.40%
Doji - Bearish? Reversal -20.40%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Imv Inc Description

IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and MSI-H solid tumors, as well as in Phase I clinical trial for breast cancer. It also develops DPX-SurMAGE that is in Phase I clinical trial for bladder cancer; and DPX-COVID-19 and DPX-RSV for infectious diseases. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada.


Keywords: Medicine Medical Specialties Cancer Clinical Medicine Infectious Diseases Breast Cancer Oncology Immunotherapy Cancer Immunotherapy Ovarian Cancer Bladder Cancer Covid 19 Diffuse Large B Cell Lymphoma

Is IMVIQ a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 0.46
52 Week Low 0.03
Average Volume 57,602
200-Day Moving Average 0.0000
50-Day Moving Average 0.0000
20-Day Moving Average 0.0000
10-Day Moving Average 0.1001
Average True Range 0.1757
RSI (14) 51.22
ADX 0.0
+DI 14.2276
-DI 3.6585
Chandelier Exit (Long, 3 ATRs) N/A
Chandelier Exit (Short, 3 ATRs) N/A
Upper Bollinger Bands 0.0000
Lower Bollinger Band 0.0000
Percent B (%b) 0.0
BandWidth 0.0000
MACD Line -0.0111
MACD Signal Line -0.0041
MACD Histogram -0.0069
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.2600
Resistance 3 (R3) 0.2800 0.2400 0.2300
Resistance 2 (R2) 0.2400 0.1942 0.2300 0.2200
Resistance 1 (R1) 0.1600 0.1658 0.1400 0.1400 0.2100
Pivot Point 0.1200 0.1200 0.1100 0.1100 0.1200
Support 1 (S1) 0.0400 0.0742 0.0200 0.0200 -0.0500
Support 2 (S2) 0.0000 0.0458 -0.0100 -0.0600
Support 3 (S3) -0.0800 0.0000 -0.0700
Support 4 (S4) -0.1000